I agree that this site is using cookies. You can find further informations here.
X
Marques Vidas, María
32  results:
Search for persons X
?
1

Strategies for prevention and treatment of SARS-COV-2 infec..:

Marques Vidas, María ; Muñez Rubio, Elena ; Quiroga, Borja...
Nefrología (English Edition).  44 (2024)  2 - p. 150-158 , 2024
Link: https://doi.org/10.1016/..
 
?
2

The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in ..:

Sánchez-Briales, Paula ; Marques Vidas, María ; López-Sánchez, Paula...
Journal of Clinical Medicine.  13 (2024)  5 - p. 1360 , 2024
Link: https://doi.org/10.3390/..
 
?
3

MO331: Acute Kidney Failure as a Risk Factor for Longer Hos..:

Portoles, Jose' M ; Lopez, Paula ; De Valdenebro Recio, Maria...
Nephrology Dialysis Transplantation.  37 (2022)  Supplement_3 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
4

MO637THE HIDDEN PREVALENCE OF DIABETIC KIDNEY DISEASE IN A ..:

Marques Vidas, Maria ; Maroto, Alba ; Domenech, Ester...
Nephrology Dialysis Transplantation.  36 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
5

MO652EFFECT OF ESTIMATED GLOMERULAR FILTRATION RATE (EGFR) ..:

Maroto, Alba ; Domenech, Ester ; Marques Vidas, Maria..
Nephrology Dialysis Transplantation.  36 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
6

MO813ANALYSING TRANSITIONS IN THE INTEGRATED MODEL OF RENAL..:

Gil-Casares Casanova, Beatriz ; Portoles, Jose ; López, Paula...
Nephrology Dialysis Transplantation.  36 (2021)  Supplement_1 - p. , 2021
Link: https://doi.org/10.1093/..
 
?
7

P1009RENAL OUTCOMES IN DIABETIC KIDNEY PATIENTS TREATED WIT..:

Portoles, Jose' M ; López, Paula ; Sanz, Ignacio..
Nephrology Dialysis Transplantation.  35 (2020)  Supplement_3 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
8

P1047URICOSURIA AND URINARY GLUCOSE EXCRETION ON DIABETIC K..:

Portoles, Jose' M ; López, Paula ; Sanz, Ignacio..
Nephrology Dialysis Transplantation.  35 (2020)  Supplement_3 - p. , 2020
Link: https://doi.org/10.1093/..
 
?
9

Statins and antiplatelet agents are associated with changes..:

García Menéndez, Estefanya ; Marques Vidas, María ; Alique, Matilde...
Nefrología (English Edition).  39 (2019)  3 - p. 287-293 , 2019
Link: https://doi.org/10.1016/..
 
?
10

El uso de estatinas y antiagregantes se asocia con cambios ..:

García-Menéndez, Estefanya ; Marques Vidas, María ; Alique, Matilde...
Nefrología.  39 (2019)  3 - p. 287-293 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Dapagliflozin-induced hypercalcemia:

Marques Vidas, María ; Dura Gurpide, Beatriz ; Rubio, Esther..
Nefrología (English Edition).  38 (2018)  3 - p. 336-337 , 2018
Link: https://doi.org/10.1016/..
 
?
12

Hipercalcemia inducida por dapagliflozina:

Marques Vidas, María ; Dura Gurpide, Beatriz ; Rubio, Esther..
Nefrología.  38 (2018)  3 - p. 336-337 , 2018
Link: https://doi.org/10.1016/..
 
?
13

#5867 EFFECT OF SGLT2I ON URIC ACID AND GLUCOSE URINARY FRA..:

Briales, Paula Sanchez ; Vidas, Maria Marques ; López, Paula...
Nephrology Dialysis Transplantation.  38 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
14

#4117 HYPERKALIEMIA TREATMENT APPROACH BY THE NEPHROLOGIST:..:

Vidas, Maria Marques ; Molina, Fernando Tornero ; Rubio, María Auxiliadora Bajo...
Nephrology Dialysis Transplantation.  38 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
15

#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHR..:

Vidas, Maria Marques ; López, Paula ; Briales, Paula Sanchez..
Nephrology Dialysis Transplantation.  38 (2023)  Supplement_1 - p. , 2023
Link: https://doi.org/10.1093/..
 
1-15